RHEUMATOLOGY INTERNATIONAL（国际风湿病学杂志）影响因子_期刊投稿发表

期刊简介

RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology.RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production.Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.

《国际风湿病学》是一份独立的杂志，反映了世界范围内在各种风湿性疾病的研究，诊断和治疗方面的进展。它旨在为风湿病领域的研究人员和临床医生提供服务。国际风湿病将涵盖临床研究以及风湿病管理的所有现代趋势。将特别强调与风湿病有关的公共卫生问题，将风湿病学研究应用于临床实践，风湿病的流行病学，风湿病的诊断测试，风湿病学患者报告的结果 (pro) 以及风湿病学教育的证据。对这些主题的贡献将以原始出版物，简短通讯，社论和评论的形式出现。欢迎 “给编辑的信” 作为讨论的增强。不鼓励提交包括体外或动物研究在内的基础科学研究，因为我们只会从流行病学或临床角度审查关于人类的研究。没有对文献进行适当审查的案例报告 (基于案例的审查) 将不会发布。将尽一切努力确保出版速度，同时保持高标准的内容和制作。提交出版的手稿必须包含一份声明，大意是所有人类研究都经过了适当的伦理委员会的审查，因此已经按照适当版本中规定的道德标准进行了执行赫尔辛基1964宣言。案文中还应明确指出，所有人在纳入研究之前均已知情同意。可能透露被研究对象身份的细节应省略。

《RHEUMATOLOGY INTERNATIONAL》期刊已被查看：次

分区信息